Related Articles
Anticancer effects and mechanisms of astragaloside‑IV (Review)
Molecular mechanisms of astragaloside‑IV in cancer therapy (Review)
Transforming growth factor-β1-induced epithelial-mesenchymal transition in human esophageal squamous cell carcinoma via the PTEN/PI3K signaling pathway
Astragaloside IV inhibits metastasis in hepatoma cells through the suppression of epithelial-mesenchymal transition via the Akt/GSK-3β/β-catenin pathway
RhoC is essential in TGF‑β1 induced epithelial‑mesenchymal transition in cervical cancer cells